We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $127B Turnover 40.17%
1-Year Est. Return 46.06%
This Fund
S&P 500
This Quarter Est. Return
+16.68%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$88.8B
AUM Growth
+$10B
Cap. Flow
-$53.4M
Cap. Flow %
-0.06%
Top 10 Hldgs %
31.47%
Holding
3,325
New
753
Increased
947
Reduced
893
Closed
691
Avg Time Held Equity + Options
0.9 years
Top 10 Avg Time Held Equity + Options
2.1 years
Top 20 Avg Time Held Equity + Options
1.2 years
Avg Time Held Equity only
0.9 years
Top 10 Avg Time Held Equity only
2.2 years
Top 20 Avg Time Held Equity only
1.3 years

Top Buys

Rank Stock Value
1
CRCL icon
Circle Internet Group
CRCL
+$1.39B
2
NVDA icon
NVIDIA
NVDA
+$910M
3
AMZN icon
Amazon
AMZN
+$440M
4
TMUS icon
T-Mobile US
TMUS
+$432M
5
LLY icon
Eli Lilly
LLY
+$398M

Top Sells

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.3B
2
TSLA icon
Tesla
TSLA
+$880M
3
DHR icon
Danaher
DHR
+$535M
4
INTU icon
Intuit
INTU
+$467M
5
V icon
Visa
V
+$437M

Sector Composition

Rank Sector Weight
1 Miscellaneous 22.16%
2 Technology 19.88%
3 Consumer Discretionary 13.54%
4 Healthcare 10.42%
5 Financials 8.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
HTO icon
476
H2O America
HTO
$2.4B
$26.4M 0.03%
507,568
+237,069
+88% +$12.6M
2025 Q1
1 quarter
ABR icon
477
Arbor Realty Trust
ABR
$522M
$26.4M 0.03%
+2,463,395
New +$25.9M
2025 Q2
0 quarters
PTCT icon
478
PTC Therapeutics
PTCT
$5.09B
$26.3M 0.03%
537,776
-203,226
-27% -$9.65M
2025 Q1
1 quarter
BKR icon
479
Baker Hughes
BKR
$54B
$26.1M 0.03%
681,067
+621,275
+1,039% +$23.4M
2024 Q1
5 quarters
STOK icon
480
Stoke Therapeutics
STOK
$1.59B
$26.1M 0.03%
2,300,554
+168,771
+8% +$1.6M
2024 Q1
5 quarters
HUN icon
481
Huntsman Corp
HUN
$1.5B
$26M 0.03%
2,498,090
-324,331
-11% -$3.95M
2024 Q1
5 quarters
BCS icon
482
Barclays
BCS
$76B
$25.9M 0.03%
1,394,990
+1,280,586
+1,119% +$21.2M
2024 Q4
2 quarters
RYAN icon
483
Ryan Specialty Holdings
RYAN
$4.89B
$25.8M 0.03%
380,116
+223,124
+142% +$15.4M
2024 Q3
3 quarters
OVV icon
484
Ovintiv
OVV
$18.3B
$25.8M 0.03%
677,481
+267,173
+65% +$9.8M
2024 Q4
2 quarters
ARLO icon
485
Arlo Technologies
ARLO
$1.34B
$25.6M 0.03%
1,510,603
+792,294
+110% +$10.1M
2025 Q1
1 quarter
GWRE icon
486
Guidewire Software
GWRE
$14.4B
$25.5M 0.03%
108,349
+103,649
+2,205% +$22.3M
2024 Q3
3 quarters
MTH icon
487
Meritage Homes
MTH
$3.93B
$25.5M 0.03%
380,262
-257,562
-40% -$17.1M
2024 Q4
2 quarters
PCG icon
488
PG&E
PCG
$38.9B
$25.4M 0.03%
1,823,736
+1,679,180
+1,162% +$27.3M
2023 Q3
7 quarters
NVCR icon
489
NovoCure
NVCR
$1.68B
$25.2M 0.03%
1,414,599
-392,992
-22% -$6.85M
2023 Q1
9 quarters
GLD icon
490
CALL
SPDR Gold Trust
GLD
$142B
$25.2M 0.03%
82,600
+7,600
+10% +$2.3M
2021 Q1
17 quarters
ADSK icon
491
Autodesk
ADSK
$51.2B
$25.1M 0.03%
80,987
-547,600
-87% -$155M
2022 Q3
11 quarters
ONON icon
492
On Holding
ONON
$11.8B
$25M 0.03%
480,204
-104,803
-18% -$5.34M
2024 Q3
3 quarters
MLTX icon
493
MoonLake Immunotherapeutics
MLTX
$873M
$25M 0.03%
529,211
-111,706
-17% -$4.55M
2024 Q1
5 quarters
MU icon
494
CALL
Micron Technology
MU
$1.05T
$24.8M 0.03%
201,500
+129,400
+179% +$12.1M
2024 Q1
5 quarters
CPRT icon
495
Copart
CPRT
$25.7B
$24.7M 0.03%
504,296
-621,292
-55% -$34.8M
2024 Q3
3 quarters
MAT icon
496
Mattel
MAT
$4.95B
$24.7M 0.03%
+1,252,479
New +$22.3M
2025 Q2
0 quarters
ATMU icon
497
Atmus Filtration Technologies
ATMU
$3.59B
$24.7M 0.03%
676,878
+368,125
+119% +$13.1M
2024 Q1
5 quarters
GLD icon
498
SPDR Gold Trust
GLD
$142B
$24.6M 0.03%
80,786
-84,540
-51% -$25.6M
2018 Q4
26 quarters
KRUS icon
499
Kura Sushi USA
KRUS
$475M
$24.6M 0.03%
286,075
+118,906
+71% +$7.8M
2021 Q3
15 quarters
GIL icon
500
Gildan
GIL
$7.78B
$24.6M 0.03%
+499,407
New +$22.9M
2025 Q2
0 quarters

Similar funds

Marshall Wace's Q2 2025 Portfolio in Review

As of Q2 2025, Marshall Wace held 3,325 positions worth $88.8B, up 13% from $78.8B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Marshall Wace's Q2 2025 filing shows 753 new, 947 increased, 893 reduced and 691 closed positions. Its largest new stake was Circle Internet Group: 8,534,470 shares worth $1.55B. The largest sale was iShares Core S&P 500 ETF, an estimated $1.3B.

By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, down from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Marshall Wace's largest Q2 2025 buy was Circle Internet Group: 8,534,470 shares worth $1.55B.
  • Marshall Wace added most to NVIDIA in Q2 2025, an estimated $910M increase.
  • Marshall Wace's biggest Q2 2025 reduction was iShares Core S&P 500 ETF, cutting an estimated $1.3B.
  • Marshall Wace fully exited Cboe Global Markets in Q2 2025, selling an estimated $191M.
  • Marshall Wace's ten largest holdings make up 31% of its $88.8B portfolio in Q2 2025.
  • Marshall Wace opened 753 new positions and closed 691 in Q2 2025.
  • Marshall Wace's portfolio value rose 13% quarter-over-quarter to $88.8B.

Based on Marshall Wace's 13F filing for Q2 2025, filed 13 Aug 2025.